A statistical model describing combined irreversible electroporation and electroporation-induced blood-brain barrier disruption
By:
References
- Weaver JC. Electroporation of biological membranes from multicellular to nano scales.IEEE Trans Dielectr Electr Insul 2013;10: 754–68.
- Kotnik T, Kramar P, Pucihar G, Miklavčič D, Tarek M. Cell membrane electroporation-Part 1: The phenomenon.IEEE Elect Insul Mag 2012;28: 14–23.
- Yarmush ML, Golberg A, Serša G, Kotnik T, Miklavčič D. Electroporation-based technologies for medicine: principles, applications, and challenges.Annu Rev Biomed Eng 2014;16: 295–320.
- Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation.Ann Biomed Eng 2005;33: 223–31.
- Garcia PA, Rossmeisl JH, Jr., Robertson JL, Olson JD, Johnson AJ, Ellis TL, et al. 7.0-T magnetic resonance imaging characterization of acute blood-brain-barrier disruption achieved with intracranial irreversible electroporation.PloS One 2012;7: e50482.
- Hjouj M, Last D, Guez D, Daniels D, Sharabi S, Lavee J, et al. MRI study on reversible and irreversible electroporation induced blood brain barrier disruption.PloS One 2012;7: e42817.
- Sharabi S, Last D, Guez D, Daniels D, Hjouj MI, Salomon S, et al. Dynamic effects of point source electroporation on the rat brain tissue.Bioelectrochemistry 2014;99: 30–9.
- Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, et al. Electrochemotherapy: a new technological approach in treatment of metastases in the liver.Technol Cancer Res Treat 2011;10: 475–85.
- Kwon D, McFarland K, Velanovich V, Martin RC, 2nd. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.Surgery 2014;156: 910–20.
- Linnert M, Iversen HK, Gehl J. Multiple brain metastases - current management and perspectives for treatment with electrochemotherapy.Radiol Oncol 2012;46: 271–8.
- Mevio N, Bertino G, Occhini A, Scelsi D, Tagliabue M, Mura F, et al. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results.Tumori 2012;98: 308–13.
- Miklavcic D, Mali B, Kos B, Heller R, Sersa G. Electrochemotherapy: from the drawing board into medical practice.Biomed Eng Online 2014;13: 29.
- Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, Dudeck O, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study.Cardiovasc Intervent Radiol 2011;34: 132–8.
- Philips P, Hays D, Martin RC. Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated.PloS One 2013;8: e76260.
- Scheffer HJ, Nielsen K, de Jong MC, van Tilborg AA, Vieveen JM, Bouwman AR, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: A systematic review of safety and efficacy.J Vasc Interv Radiol 2014;25: 997–1011.
- Um SJ, Choi YJ, Shin HJ, Son CH, Park YS, Roh MS, et al. Phase I study of autologous dendritic cell tumor vaccine in patients with non-small cell lung cancer.Lung Cancer 2010;70: 188–94.
- Jiang C, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy.IEEE Trans Biomed Eng 2015;62: 4–20.
- Rossmeisl JH, Jr., Garcia PA, Pancotto TE, Robertson JL, Henao-Guerrero N, Neal RE 2nd, et al. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas.J Neurosurg 2015;123: 1008–25.
- Brat DJ, Van Meir EG. Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma.Lab Invest 2004;84: 397–405.
- Raza SM, Lang FF, Aggarwal BB, Fuller GN, Wildrick DM, Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.Neurosurgery 2002;51: 2–12; discussion 12–3.
- Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, et al. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors.Cancer Res 2011;71: 3753–62.
- Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy.Biomed Eng Online 2010;9: 10.
- Neal RE, 2nd, Garcia PA, Kavnoudias H, Rosenfeldt F, Mclean CA, Earl V, et al. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models.IEEE Trans Biomed Eng 2015;62: 561–9.
- Pavliha D, Kos B, Marcan M, Zupanic A, Sersa G, Miklavcic D. Planning of electroporation-based treatments using Web-based treatment-planning software.J Membr Biol 2013;246: 833–42.
- Pavliha D, Music MM, Sersa G, Miklavcic D. Electroporation-based treatment planning for deep-seated tumors based on automatic liver segmentation of MRI images.PloS One 2013;8: e69068.
- Zupanic A, Kos B, Miklavcic D. Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation.Phys Med Bio 2012;57: 5425–40.
- Groselj A, Kos B, Cemazar M, Urbancic J, Kragelj G, Bosnjak M, et al. Coupling treatment planning with navigation system: a new technological approach in treatment of head and neck tumors by electrochemotherapy.Biomed Eng Online 2015;14 Suppl 3: S2.
- Miklavcic D, Davalos RV. Electrochemotherapy (ECT) and irreversible electroporation (IRE) -advanced techniques for treating deep-seated tumors based on electroporation.Biomed Eng Online 2015;14 Suppl 3: 11.
- Kranjc M, Markelc B, Bajd F, Čemažar M, Serša I, Blagus T, et al. In situ monitoring of electric field distribution in mouse tumor during electroporation.Radiology 2015;274: 115–23.
- Qin Z, Jiang J, Long G, Lindgren B, Bischof JC. Irreversible electroporation: an in vivo study with dorsal skin fold chamber.Ann Biomed Eng 2013;41: 619–29.
- Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy.Biochim Biophys Acta 2000;1523: 73–83.
- Golberg A, Rubinsky B. A statistical model for multidimensional irreversible electroporation cell death in tissue.Biomed Eng Online 2010;9: 13.
- Dermol J, Miklavčič D. Predicting electroporation of cells in an inhomogeneous electric field based on mathematical modeling and experimental CHO-cell permeabilization to propidium iodide determination.Bioelectrochemistry 2014;100: 52–61.
- Garcia PA, Davalos RV, Miklavcic D. A numerical investigation of the electric and thermal cell kill distributions in electroporation-based therapies in tissue.PloS One 2014;9: e103083.
- Dermol J, Miklavcic D. Mathematical models describing Chinese hamster ovary cell death due to electroporation in vitro.J Membr Biol 2015;248: 865–81.
- Peleg M. A model of microbial survival after exposure to pulsed electric fields.J Sci Food Agric 1995;67: 93–9.
- Sel D, Lebar AM, Miklavcic D. Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization.IEEE Trans Biomed Eng 2007;54: 773–81.
- Miklavcic D, Towhidi L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells.Radiol Oncol 2010;44: 34–41.
- Corovic S, Lackovic I, Sustaric P, Sustar T, Rodic T, Miklavcic D. Modeling of electric field distribution in tissues during electroporation.Biomed Eng Online 2013;12: 16.
- Elwassif MM, Kong Q, Vazquez M, Bikson M. Bio-heat transfer model of deep brain stimulation-induced temperature changes.J Neural Eng 2006;3: 306–15.
- Garcia PA, Rossmeisl JH, Jr., Neal RE, 2nd, Ellis TL, Olson JD, Henao-Guerrero N, et al. Intracranial nonthermal irreversible electroporation: in vivo analysis.J Membr Biol 2010;236: 127–36.
- Garcia PA, Rossmeisl JH, Jr., Neal RE, 2nd, Ellis TL, Davalos RV. A parametric study delineating irreversible electroporation from thermal damage based on a minimally invasive intracranial procedure.Biomed Eng Online 2011;10: 34.
- Lagarias JC, Reeds JA, Wright MH, Wright PE. Convergence properties of the Nelder--Mead simplex method in low dimensions.SIAM J Optim 1998;9: 112–47.
- Pucihar G, Krmelj J, Rebersek M, Napotnik TB, Miklavcic D. Equivalent pulse parameters for electroporation.IEEE Trans Biomed Eng 2011;58: 3279–88.
- Sherar M, Moriarty J, Kolios M, Chen JC, Peters RD, Ang LC, et al. Comparison of thermal damage calculated using magnetic resonance thermometry, with magnetic resonance imaging post-treatment and histology, after interstitial microwave thermal therapy of rabbit brain.Phys Med Bio 2000;45: 3563–76.
- Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels.Technol Cancer Res Treat 2007;6: 307–12.
- Nieto-Sampedro M, Valle-Argos B, Gomez-Nicola D, Fernandez-Mayoralas A, Nieto-Diaz M. Inhibitors of glioma growth that reveal the tumour to the immune system.Clin Med Onco 2011;5: 265–314.
- Faroja M, Ahmed M, Appelbaum L, Ben-David E, Moussa M, Sosna J, et al. Irreversible electroporation ablation: Is all the damage nonthermal?Radiology 2013;266: 462–70.
- Olweny EO, Kapur P, Tan YK, Park SK, Adibi M, Cadeddu JA. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.Urology 2013;81: 679–84.
- Peleg M. Evaluation of the Fermi equation as a model of dose-response curves.Appl Microbiol Biotechnol 1996;46: 303–6.
- Pucihar G, Krmelj J, Rebersek M, Napotnik T, Miklavcic D. Equivalent pulse parameters for electroporation.IEEE Trans Biomed Eng 2011;58: 3279–88.
- Garcia PA, Neal RE, Rossmeisl JH, Davalos RV. Non-thermal irreversible electroporation for deep intracranial disorders.Conf Proc IEEE Eng Med Biol Soc 2010;2010: 2743–6.
- Ellis TL, Garcia PA, Rossmeisl JH, Jr., Henao-Guerrero N, Robertson J, Davalos RV. Nonthermal irreversible electroporation for intracranial surgical applications. Laboratory investigation.J Neurol 2011;114: 681–8.
- Kos B, Voigt P, Miklavcic D, Moche M. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).Radiol Oncol 2015;49: 234–41.
Language: English
Page range: 28 - 38
Submitted on: Oct 23, 2015
Accepted on: Jan 3, 2016
Published on: Feb 16, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2016 Shirley Sharabi, Bor Kos, David Last, David Guez, Dianne Daniels, Sagi Harnof, Yael Mardor, Damijan Miklavcic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.